These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 18313835

  • 1. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K.
    Mol Cell Endocrinol; 2008 Mar 26; 285(1-2):10-8. PubMed ID: 18313835
    [Abstract] [Full Text] [Related]

  • 2. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells.
    Tsugita M, Iwasaki Y, Nishiyama M, Taguchi T, Shinahara M, Taniguchi Y, Kambayashi M, Terada Y, Hashimoto K.
    Life Sci; 2008 Sep 12; 83(11-12):426-32. PubMed ID: 18692075
    [Abstract] [Full Text] [Related]

  • 3. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH, Walker BR.
    Minerva Endocrinol; 2007 Sep 12; 32(3):141-59. PubMed ID: 17912154
    [Abstract] [Full Text] [Related]

  • 4. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C.
    Int J Obes (Lond); 2007 Dec 12; 31(12):1826-31. PubMed ID: 17593901
    [Abstract] [Full Text] [Related]

  • 5. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M.
    Handb Exp Pharmacol; 2011 Dec 12; (203):127-46. PubMed ID: 21484570
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts.
    Sun K, Myatt L.
    Endocrinology; 2003 Dec 12; 144(12):5568-77. PubMed ID: 12960005
    [Abstract] [Full Text] [Related]

  • 7. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation.
    Cooper MS, Bujalska I, Rabbitt E, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM.
    J Bone Miner Res; 2001 Jun 12; 16(6):1037-44. PubMed ID: 11393780
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB.
    Obesity (Silver Spring); 2008 Apr 12; 16(4):731-5. PubMed ID: 18379559
    [Abstract] [Full Text] [Related]

  • 9. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S, Quinkler M, Mai K, Schöneshöfer M, Baehr V, Pfeiffer A, Oelkers W, Eigendorff E.
    Horm Metab Res; 2011 Jan 12; 43(1):66-71. PubMed ID: 20925019
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM.
    Am J Physiol Endocrinol Metab; 2009 Feb 12; 296(2):E367-77. PubMed ID: 19088256
    [Abstract] [Full Text] [Related]

  • 11. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.
    Schnackenberg CG.
    Curr Opin Investig Drugs; 2008 Mar 12; 9(3):295-300. PubMed ID: 18311666
    [Abstract] [Full Text] [Related]

  • 12. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.
    Morton NM.
    Mol Cell Endocrinol; 2010 Mar 25; 316(2):154-64. PubMed ID: 19804814
    [Abstract] [Full Text] [Related]

  • 13. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
    Dzyakanchuk AA, Balázs Z, Nashev LG, Amrein KE, Odermatt A.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):137-41. PubMed ID: 18778749
    [Abstract] [Full Text] [Related]

  • 14. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
    Yang Z, Guo C, Zhu P, Li W, Myatt L, Sun K.
    J Endocrinol; 2007 Nov 25; 195(2):241-53. PubMed ID: 17951535
    [Abstract] [Full Text] [Related]

  • 15. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
    Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM.
    J Bone Miner Res; 2002 Jun 25; 17(6):979-86. PubMed ID: 12054173
    [Abstract] [Full Text] [Related]

  • 16. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
    Draper N, Stewart PM.
    J Endocrinol; 2005 Aug 25; 186(2):251-71. PubMed ID: 16079253
    [Abstract] [Full Text] [Related]

  • 17. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K, Andres J, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2007 Sep 25; 67(3):419-25. PubMed ID: 17555498
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE.
    Metabolism; 2011 Dec 25; 60(12):1775-80. PubMed ID: 21704348
    [Abstract] [Full Text] [Related]

  • 19. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
    Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A.
    Am J Physiol Endocrinol Metab; 2005 May 25; 288(5):E957-64. PubMed ID: 15613680
    [Abstract] [Full Text] [Related]

  • 20. Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats.
    Usukura M, Zhu A, Yoneda T, Karashima S, Yagi K, Yamagishi M, Takeda Y.
    Steroids; 2009 Nov 25; 74(12):978-82. PubMed ID: 19646461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.